Evidence map›Paper›PMID 25054224›Full record

ArticlePloS one2014

Single administration of p2TA (AB103), a CD28 antagonist peptide, prevents inflammatory and thrombotic reactions and protects against gastrointestinal injury in total-body irradiated mice.

Salida Mirzoeva, Tatjana Paunesku, M Beau Wanzer, Anat Shirvan, Raymond Kaempfer, Gayle E Woloschak, William Small

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Subduing the Inflammatory Cytokine Storm.International journal of molecular sciences · 2024
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Salida MirzoevaDepartment of Radiation Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America.
Tatjana PauneskuDepartment of Radiation Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America.
M Beau WanzerDepartment of Radiation Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America.
Anat ShirvanAtox Bio Ltd, Ness Ziona, Israel.
Raymond KaempferDepartment of Biochemistry and Molecular Biology, Institute of Medical Research Israel-Canada, The Hebrew University-Hadassah Medical School, Jerusalem, Israel.
Gayle E WoloschakDepartment of Radiation Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America.
William SmallDepartment of Radiation Oncology, Loyola University Stritch School of Medicine, Chicago, Illinois, United States of America.
Northwestern University · USLoyola University Chicago · US

Funding

NRG Oncology Network Group Operations Center - GY9 BIQSFP Reports/BudgetsU10CA180868 · NCI · NRG ONCOLOGY FOUNDATION, INC. · PI NORMAN WOLMARK · 2014 to 2026
$206.8M
Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Daniela E Matei · 1993 to 2026
$153.9M
RTOG Foreign AccrualU10CA021661 · NCI · AMERICAN COLLEGE OF RADIOLOGY · PI CURRAN, WALTER J. · 1985 to 2013
$150.3M
Statistics CoreU10CA180822 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Mei-Yin C Polley · 2014 to 2026
$146.4M
RTOG Foreign AccrualsU10CA037422 · NCI · AMERICAN COLLEGE OF RADIOLOGY · PI BRUNER, DEBORAH WATKINS · 1985 to 2013
$30.4M
Broad-Spectrum Antagonist of Superantigen ToxinsUC1AI067231 · NIAID · HEBREW UNIVERSITY OF JERUSALEM · PI KAEMPFER, RAYMOND O · 2005 to 2008
$5.8M
NCI NIH HHS CA060553NCI NIH HHS P30 CA060553NCI NIH HHS U10 CA021661NCI NIH HHS U10 CA037422NCI NIH HHS U10 CA180822NCI NIH HHS U10 CA180868NCI NIH HHS U10 CA21661NCI NIH HHS U10 CA37422NIAID NIH HHS UC1 AI067231NIAID NIH HHS UC1AI067231
6 · The paper itself

Abstract

The goal of this study was to elucidate the action of the CD28 mimetic peptide p2TA (AB103) that attenuates an excessive inflammatory response in mitigating radiation-induced inflammatory injuries. BALB/c and A/J mice were divided into four groups: Control (C), Peptide (P; 5 mg/kg of p2TA peptide), Radiation (R; total body irradiation with 8 Gy γ-rays), and Radiation + Peptide (RP; irradiation followed by p2TA peptide 24 h later). Gastrointestinal tissue damage was evaluated by analysis of jejunum histopathology and immunohistochemistry for cell proliferation (Cyclin D1) and inflammation (COX-2) markers, as well as the presence of macrophages (F4/80). Pro-inflammatory cytokines IL-6 and KC as well as fibrinogen were quantified in plasma samples obtained from the same mice. Our results demonstrated that administration of p2TA peptide significantly reduced the irradiation-induced increase of IL-6 and fibrinogen in plasma 7 days after exposure. Seven days after total body irradiation with 8 Gy of gamma rays numbers of intestinal crypt cells were reduced and villi were shorter in irradiated animals compared to the controls. The p2TA peptide delivery 24 h after irradiation led to improved morphology of villi and crypts, increased Cyclin D1 expression, decreased COX-2 staining and decreased numbers of macrophages in small intestine of irradiated mice. Our study suggests that attenuation of CD28 signaling is a promising therapeutic approach for mitigation of radiation-induced tissue injury.

Indexed as

Amino Acid SequenceAnimalsAntigens, DifferentiationCD28 AntigensCell ProliferationCyclin D1Cyclooxygenase 2FibrinogenGamma RaysGastrointestinal TractImmunohistochemistryInflammationInterleukin-6JejunumMacrophagesMaleAntigens, DifferentiationCD28 AntigensCyclin D1Cyclooxygenase 2FibrinogenInterleukin-6monocyte-macrophage differentiation antigenPeptidesPtgs2 protein, mouseRadiation-Protective Agents

Identifiers

PMID25054224
PMCPMC4108308
OpenAlexW2019135422

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.